TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAIncome statement

Market cap
$37.3B
P/E ratio
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Revenue16,12118,31220,31720,31420,27219,65221,90322,38518,85416,88716,65915,87814,92515,84616,544
Revenue growth (%)-
Cost of revenue7,0568,7979,6659,6079,2168,29610,04411,56010,5589,3518,9338,2847,9528,2008,481
Gross profit9,0659,51510,65210,70711,05611,35611,85910,8258,2967,5377,7267,5946,9737,6458,064
Gross margin (%)
Research & development---5-35422175114------
Operating margin (%)
Operating income 3,8713,1092,2051,6493,9513,3522,154-17,484-1,637-443-3,5721,716-2,099433-303
Income before tax 3,6462,9561,8191,2503,6382,352824-18,379-2,596-1,265-4,406658-3,065-624-1,284
Pretax margin (%)22.616.196.217.9123.8-82.1-13.8-7.5-26.44.1-20.5-3.9-7.8
Provision for income taxes283127-137-43591634521-1,933-195-278-168211-638-7676
Effective tax rate (%)
Net income 3,3392,7681,9631,2693,0551,597329-16,265-2,150-999-3,990456-2,353-559-1,639
Net income margin (%)
Earnings per share3.723.12.251.493.581.840.07-16.26-2.35-0.91-3.640.38-2.12-0.5-1.45
Diluted EPS3.673.092.251.493.561.820.07-16.26-2.35-0.91-3.640.38-2.12-0.5-1.45
Dividend payout ratio (%)-------
Dividend per share0.740.891.031.281.341.361.361.36-------